Development and regulation of stem cell‐based therapies in China
Author:
Affiliation:
1. Office of Clinical Evaluation of Biological Products Center for Drug Evaluation, National Medical Products Administration Beijing China
Publisher
Wiley
Subject
Cell Biology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.13217
Reference28 articles.
1. Stem-Cell Therapy Advances in China
2. The global landscape of stem cell clinical trials
3. Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe
4. Japan Strengthens Regenerative Medicine Oversight
5. From bench to FDA to bedside: US regulatory trends for new stem cell therapies
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Regenerative rehabilitation: a novel multidisciplinary field to maximize patient outcomes;Medical Review;2024-06-14
2. Challenges and opportunities in the development of standardized stem cell resource centers;SCIENTIA SINICA Vitae;2024-06-01
3. Tetrahedral framework nucleic acids promote the proliferation and differentiation potential of diabetic bone marrow mesenchymal stem cell;Chinese Chemical Letters;2023-12
4. Long-Term Effects of Severe Burns on the Kidneys: Research Advances and Potential Therapeutic Approaches;Journal of Inflammation Research;2023-05
5. Stem cell sources and characterization in the development of cell-based products for treating retinal disease: An NEI Town Hall report;Stem Cell Research & Therapy;2023-03-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3